Financials

	2021	2022
Net sales	-	-
Net income	-3.66Cr -2.61Cr -2.33Cr -2.16Cr -1.95Cr -248.31Cr -3.72Cr -26Cr -10Cr -129.87Cr -9.8Cr -9.59Cr -411.21Cr	-3.8Cr -2.71Cr -2.42Cr -2.24Cr -2.03Cr -257.82Cr -3.86Cr -27Cr -11Cr -134.85Cr -10Cr -9.95Cr -426.97Cr
Net Debt	-1.9Cr -1.35Cr -1.21Cr -1.12Cr -1.01Cr -128.68Cr -1.93Cr -13Cr -5.33Cr -67Cr -5.08Cr -4.97Cr -213.11Cr	76.74L 54.74L 48.95L 45.28L 41L 52Cr 78L 5.45Cr 2.16Cr 27Cr 2.05Cr 2.01Cr 86Cr

Company Profile

IMV Inc. is a Canada-based company. The Company has sold all of its assets. It is not engaged in any business operations.

Employees

Sector

Date	Price	Change	Volume

Delayed Quote OTC Markets

Market Closed - OTC Markets 07:26:12 20/10/2026 pm IST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-

24/24/24	OPEC excited about Namibia partnership, offers support	RE
16/23/16	IMV Inc., Q4 2022 Earnings Call, Mar 16, 2023

24/24/24	OPEC excited about Namibia partnership, offers support	RE
16/23/16	IMV Inc., Q4 2022 Earnings Call, Mar 16, 2023
11/22/11	IMV Inc., Q3 2022 Earnings Call, Nov 11, 2022
11/22/11	IMV Inc., Q2 2022 Earnings Call, Aug 11, 2022
29/22/29	IMV Inc. - Shareholder/Analyst Call

04/23/04	IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets	AQ
14/19/14	IMV Inc. : to Present at Two Upcoming Investor Conferences	BU
12/19/12	Imv : New Phase 2 Clinical Trial Results Continue to Demonstrate Potential Clinical Benefit of IMV’s DPX-Survivac in Combination with Merck’s Keytruda in Patients with DLBCL	BU

Manager	Title	Age	Since
Stéphane Fiset CTO	Chief Tech/Sci/R&D Officer	-	-
Tracy Sherren SEC	Corporate Secretary	60	-
Marie-Eve Charrois LAW	General Counsel	-	-

Director	Title	Age	Since
Markus Warmuth BRD	Director/Board Member	55	06/11/2018
Michael Bailey CHM	Chairman	60	01/05/2022
Michael Kalos BRD	Director/Board Member	64	11/05/2021

Date	Insider	Type	Main position	Quantity	% Market Cap.
06/04/23	Shabnam Kazmi	Option	Director	48,259	0.4121%
06/04/23	Michael Kalos	Option	Director	52,378	0.4472%
06/04/23	Markus Warmuth	Option	Director	56,007	0.4782%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IMV INC.	0.00%	0.00%	-	-	14
INVESTOR AB	+0.62%	+1.92%	+30.69%	+108.03%	13TCr
INDUSTRIVÄRDEN AB	+0.49%	+0.98%	+29.39%	+82.98%	2.22TCr
HAL TRUST	-0.24%	+2.56%	+22.92%	+59.17%	1.7TCr
MERITZ FINANCIAL GROUP INC.	-2.03%	-4.43%	+10.11%	+153.44%	1.52TCr
LUNDBERG B	+0.65%	+1.76%	+12.02%	+28.87%	1.43TCr
INVESTMENT AB LATOUR	+0.94%	+3.33%	-13.49%	+15.10%	1.36TCr
BAJAJ HOLDINGS & INVESTMENT LIMITED	-1.65%	-0.98%	-16.32%	+60.97%	1.29TCr
WASHINGTON H. SOUL PATTINSON AND COMPANY LIMITED	-0.52%	-0.54%	+21.32%	+34.81%	1.22TCr
KINGDOM HOLDING COMPANY	+2.91%	-5.12%	+53.38%	+72.25%	1.16TCr
Average	+0.12%	-1.12%	+16.67%	+68.40%	2.47TCr
Weighted average by Cap.	+0.34%	-0.60%	+23.40%	+87.73%